This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 4 EPO patents. Top assignees: Next Biomed Therapies Oy, Friedrich-Alexander-Universitat Erlangen-Nürnberg, Licentia, Ltd.. Active years: 2004-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Helsinki, FI (2004 - 2014)
- Espoo, FI (2020 - 2021)
Company Filing History:
2 out of 2 
1 out of 116 
1 out of 20 
Years Active: 2004-2026
Title: Kalle Saksela: Innovator in Biomedicine
Introduction
Kalle Saksela is a prominent inventor based in Espoo, Finland. He has made significant contributions to the field of biomedicine, particularly through his innovative patents. With a total of 5 patents, Saksela's work focuses on advancing medical technologies and methodologies.
Latest Patents
One of his latest patents is centered around SH3 domain derivatives. This invention is directed to SH3 domain derivatives that possess a specific binding affinity to target molecules. It provides SH3 domain derivatives of nephrocystin (NPHP1) and the Tec kinase. Additionally, the invention outlines a method for producing a library of recombinant derivatives of NPHP1 or the Tec kinase SH3 domains, along with a method for selecting derivatives with specific binding affinities.
Another notable patent involves a method for in vitro detection and monitoring of diseases. This method is based on measuring disease-associated protease activity in extracellular vesicles. It includes modified peptides for enzymatic detection of proteases, the use of these peptides, and a kit comprising such peptides. This invention is particularly relevant for monitoring infectious, inflammatory, and malignant diseases, such as HIV infection and melanoma.
Career Highlights
Throughout his career, Kalle Saksela has worked with various companies, including Licentia Ltd. and Next Biomed Therapies Oy. His experience in these organizations has contributed to his expertise in biomedicine and innovation.
Collaborations
Saksela has collaborated with notable individuals in his field, including Marita Hiipakka and Andreas Baur. These collaborations have further enriched his research and development efforts.
Conclusion
Kalle Saksela is a distinguished inventor whose work in biomedicine has led to significant advancements. His innovative patents and collaborations reflect his commitment to improving medical technologies. His contributions continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile